Container Closure Integrity Testing in Pharmaceutical Stability Studies
Container Closure Integrity Testing in Pharmaceutical Stability Studies
Tag: FDA CCI expectations
Container Closure Integrity Testing in Biologic Stability Studies
Container Closure Integrity Testing in Biologic Stability Studies Ensuring Sterility and Stability: Container Closure Integrity Testing for Biologics Container Closure Integrity Testing (CCIT) is an essential part of biopharmaceutical product development, ensuring that the packaging system maintains its barrier properties throughout the product’s shelf life. For sterile biologic products—particularly parenterals—container closure integrity (CCI) directly impacts…
Read More “Container Closure Integrity Testing in Biologic Stability Studies” »